LOS ANGELES, April 27, 2017 -- Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Amyris, Inc. (“Amyris” or the “Company”) (Nasdaq:AMRS) concerning possible violations of federal securities laws. Investors who purchased shares between March 2, 2017 and April 17, 2017 inclusive (the “Class Period”), should contact the firm prior to the June 19, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected].
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the Complaint, during the Class Period, Amyris made false and/or misleading statements and/or failed to disclose: that in the first quarter of 2017, the Company made a decision to take an equity stake in one of Blue California’s affiliates that focused on the sweetener market instead of cash payment under the license agreement; that due to this decision Amyris would be unable to recognize $10 million in fourth quarter and fiscal year 2016 revenue from the license agreement with Blue California; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. When this news was released, shares of Amyris declined in value materially, which harmed investors according to the Complaint.
Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethical rules.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/


Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO 



